XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2
SHAREHOLDERS’ EQUITY (Tables)
 9 Months Ended
May 31, 2022
Equity [Abstract]  
Schedule of Common Stock Outstanding Roll Forward
Shares of common stock outstanding for the three and nine months ended May 31, 2022 and 2021 were as follows:
Three Months Ended
May 31,		Nine Months Ended
May 31,
2022202120222021
Common stock outstanding, beginning of the period20,181,784 20,059,528 20,141,521 19,923,277 
Common stock issued during the period52,870 61,512 93,133 197,763 
Common stock outstanding, end of the period20,234,654 20,121,040 20,234,654 20,121,040 
Schedule of Dividends Payable
Our Board of Directors declared cash dividends during fiscal years 2022 and 2021. The details of the dividends paid are in the following tables:
(in thousands, except dividend per share)Fiscal Year 2022
Record DateDistribution DateNumber of Shares
Outstanding on
Record Date		Dividend per
Share		Total Amount
10/25/202111/01/202120,148 $0.06 1,209 
1/31/20222/07/202220,178 $0.06 1,211 
4/25/20225/02/202220,207 $0.06 1,212 
Total$3,632 
(in thousands, except dividend per share)Fiscal Year 2021
Record DateDistribution DateNumber of Shares
Outstanding on
Record Date		Dividend per
Share		Total Amount
10/26/202011/02/202019,924 $0.06 $1,195 
1/25/20212/01/202120,010 $0.06 1,201 
4/26/20215/03/202120,115 $0.06 1,207 
7/26/20218/02/202120,139 $0.06 1,208 
Total$4,811 
Share-based Payment Arrangement, Option, Activity
The following table summarizes information about stock options:
(in thousands, except per share and weighted-average amounts)Number of
Options 		Weighted-
Average
Exercise
Price
Per Share		Weighted-
Average
Remaining
Contractual
Life (Years)
Transactions during the nine months ended May 31, 2022
Outstanding, August 31, 20211,184 $25.63 6.47
Granted232 $41.40 
Exercised(76)$15.93 
Cancelled/Forfeited(64)$41.04 
Outstanding, May 31, 20221,276 $28.31 6.33
Exercisable, May 31, 2022722 $16.96 4.66
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
The following table summarizes the fair value of the options, including both ISOs and NQSOs, granted during the nine months ended May 31, 2022 and fiscal year 2021:
(in thousands except pricing)Nine Months Ended
May 31, 2022		Fiscal Year 2021
Estimated fair value of awards granted$4,066 $— $5,092 
Unvested forfeiture rate1 %0 %
Weighted average grant price$41.40 $57.60 
Weighted average market price$41.40 $57.60 
Weighted average volatility42.71 %40.49 %
Weighted average risk-free rate1.62 %0.64 %
Weighted average dividend yield0.59 %0.42 %
Weighted average expected life6.59 years6.63 years
Share-based Payment Arrangement, Option, Exercise Price Range
The exercise prices for the options outstanding at May 31, 2022 ranged from $6.85 to $66.14, and the information relating to these options is as follows:
(in thousands except prices)
Exercise PriceAwards OutstandingAwards Exercisable
LowHighQuantityWeighted
Average
Remaining
Contractual
Life		Weighted
Average
Exercise
Price		QuantityWeighted
Average
Remaining
Contractual
Life		Weighted
Average
Exercise
Price
$6.85 $9.77 296 3.02 years$8.33 296 3.02 years$8.33 
$9.78 $18.76 208 4.58 years$10.37 207 4.58 years$10.35 
$18.77 $33.40 253 6.64 years$25.15 129 6.26 years$24.11 
$33.41 $47.63 240 8.86 years$38.37 34 7.31 years$35.75 
$47.64 $66.14 279 8.69 years$57.06 56 8.39 years$58.93 
1,276 6.33 years$28.31 722 4.66 years$16.96